Patent ID: 8119133

Claim:
A binding compound that binds to human IL-23R comprising: a) an antibody light chain variable domain, or antigen binding fragment thereof, comprising CDRL1, CDRL2 and CDRL3, wherein: CDRL1 comprises the sequence of SEQ ID NO: 29 or 52; CDRL2 comprises the sequence of SEQ ID NO: 34; and CDRL3 comprises the sequence of SEQ ID NO: 39; and b) an antibody heavy chain variable domain, or antigen binding fragment thereof, comprising CDRH1, CDRH2 and CDRH3, wherein: CDRH1 comprises the sequence of SEQ ID NO: 14; CDRH2 comprises the sequence of SEQ ID NO: 19; and CDRH3 comprises the sequence of SEQ ID NO: 24.